You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.

Open menu

News

Data delivery: Sanofi and GSK seek authorisation for COVID-19 vaccine

Sanofi and GlaxoSmithKline (GSK) have announced that they will submit data from both their booster and phase 3 effectiveness trials, thereby forming the basis for their COVID-19 vaccine regulatory applications.